The UK-based specialist finance provider said the deal marks the sixth renewal and upsize of its type between the two ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

The research team at J.P. Morgan is out with the firm's 2025 Year Ahead Best Idea list, and we found five companies that look ...

As the healthcare and life sciences industry gears up for the highly anticipated JP Morgan Healthcare Conference later this ...

Wall Street bank JP Morgan has filed two lawsuits over its investment in fintech Viva Wallet, the latest twist in a legal ...

The bank, which has been under review by the Texas attorney general over its involvement in the Net-Zero Banking Alliance, ...

JP Morgan goes all out with strict RTO policy, insisting all employees are back at their desks for the full week.

J.P. Morgan releases its quarterly look-ahead days before the entire biopharma industry descends on San Francisco for the ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Fintel reports that on January 7, 2025, JP Morgan downgraded their outlook for Raymond James Financial, Inc. - Preferred ...

Fintel reports that on January 7, 2025, JP Morgan upgraded their outlook for Ultrapar Participações S.A. - Depositary Receipt ...

Over the past decade, corporate investment in India has dropped significantly by 12 percent of GDP and policies should focus ...